Schenkein David P - Insider Non-Derivative Transactions at REGENERON PHARMACEUTICALS, INC. (REGN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 2, 2024, Schenkein David P's relationship to REGENERON PHARMACEUTICALS, INC. (REGN) is Director, and currently has 282 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other REGN insiders.

Data Source: SEC.
Schenkein David P - Insider Non-Derivative Transactions of REGN Common Stock
Schenkein David P - Insider Non-Derivative Transactions at REGN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 3, 2024 Acquisition -- (Common Stock) 42 0 282
Sep 9, 2023 Acquisition -- (Common Stock) 240 0 240